BDX Q3 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.3B+1.7% YoY

Gross Profit

$2.1B47.7% margin

Operating Income

$626M14.4% margin

Net Income

$451M10.4% margin

EPS (Diluted)

$1.51

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$933M

Free Cash Flow

$696M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$52.2B

Total Liabilities

$30.7B

Stockholders' Equity

$21.5B

Cash & Equivalents

$523M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.3B	$4.3B	+1.7%
Gross Profit	$2.1B	$2.0B	+2.9%
Operating Income	$626M	$512M	+22.3%
Net Income	$451M	$594M	-24.1%

Revenue Segments

Medical

$2.3B53%

Life Sciences

$1.1B24%

Interventional

$981M23%

Geographic Segments

UNITED STATES

$2.4B56%

Non-US

$1.9B44%